These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37343924)

  • 1. Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey.
    Yıldırım S; Erkoyun E; Alpdoğan Ö; Yılmaz HO; Yılmaz B; Erdal Dönmez G; Sarıtaş A; Gökmen N; Ergan B; Bayrak V; Yakar MN; Kılıç Ö; Kılınç A; Saygılı S; Gaygısız Ü; Aydın K; Özel Yeşilyurt A; Cankar Dal H; Bayındır Dicle Ç; Turan S; Binay S; Yarıcı M; Yıldırım F; Hancı P; İnal MT; Akbaş T; Eyüpoğlu S; Albayrak T; Koçak G; Çakır T; Yüksel RC; Sarı A; Güneş M; Menteş O; Yamanel HL; Kirakli C
    J Infect Chemother; 2023 Oct; 29(10):959-964. PubMed ID: 37343924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19.
    van Diepen S; McAlister FA; Chu LM; Youngson E; Kaul P; Kadri SS
    Crit Care Med; 2023 Sep; 51(9):1201-1209. PubMed ID: 37192450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoidable intensive care unit resource use and costs of unvaccinated patients with COVID-19: a historical population-based cohort study.
    Bagshaw SM; Abbott A; Beesoon S; Zuege DJ; Wasylak T; Manns B; Nguyen TX
    Can J Anaesth; 2022 Nov; 69(11):1399-1404. PubMed ID: 35879485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.
    Whittaker R; Bråthen Kristofferson A; Valcarcel Salamanca B; Seppälä E; Golestani K; Kvåle R; Watle SV; Buanes EA
    Clin Microbiol Infect; 2022 Jun; 28(6):871-878. PubMed ID: 35219807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of Vaccinated and Unvaccinated Hospitalised Patients: A Retrospective Population Study of 500 Hospitalised Patients with SARS-CoV-2 Infection in a Spanish Population of 220,000 Inhabitants.
    Ruiz-Giardin JM; Rivilla M; Mesa N; Morales A; Rivas L; Izquierdo A; Escribá A; San Martín JV; Bernal-Bello D; Madroñal E; Farfán AI; Guerrero M; Calderón R; Duarte MA; Piedrabuena SI; Toledano-Macías M; Satué JÁ; Marrero J; de Ancos CL; Frutos B; Cristóbal R; Soria G; Ayala-Larrañaga I; Carpintero L; de Hita M; Lara C; Llerena ÁR; García V; Jiménez R; García V; Saiz-Lou EM; Prieto S; González-Pereira N; Lechuga LA; Tarancón J; Gonzalo S;
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of critically ill patients with one, two and three doses of vaccination against COVID-19 in Australia.
    Otto M; Burrell AJC; Neto AS; Alliegro PV; Trapani T; Cheng A; Udy AA;
    Intern Med J; 2023 Mar; 53(3):330-338. PubMed ID: 35841294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A national cohort study in Iran.
    Jamaati H; Karimi S; Ghorbani F; Panahi Y; Hosseini-Baharanchi FS; Hajimoradi M; Malek R; Noorali S; Mokhtari M; Khoundabi B; Sadr M; Mohamadnia A; Zahraei SM; Hashemian SM; Dastan F; Mortaz E; Tayeri K; Behtaj F; Vaezi H; Forouzanfar MM; Shafaghi S
    J Med Virol; 2023 Mar; 95(3):e28607. PubMed ID: 36815507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
    Sevinc SA; Metin S; Basi NB; Ling J; Cinar AS; Oba S
    Epidemiol Infect; 2022 Feb; 150():e35. PubMed ID: 35135644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical outcomes of vaccinated and unvaccinated patients with hospitalization for COVID-19.
    Ozdemir YE; Kizilcay B; Sonmezisik M; Tarhan MS; Borcak D; Sahin Ozdemir M; Bayramlar OF; Yesilbag Z; Senoglu S; Gedik H; Kumbasar Karaosmanoglu H; Kart Yasar K
    Acta Microbiol Immunol Hung; 2022 Dec; 69(4):270-276. PubMed ID: 36129790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Observational Study on Patients With COVID-19 Infection Admitted to the Intensive Care Unit With Respect to Their Vaccination Status.
    Ghosh S; Sinha S; Bhattacharyya M; Biswas C; Todi S; Kundu R
    Cureus; 2023 Apr; 15(4):e37159. PubMed ID: 37168153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    Bakasis AD; Mavragani CP; Voulgari PV; Gerolymatou N; Argyropoulou OD; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
    J Autoimmun; 2022 Jul; 131():102846. PubMed ID: 35717727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    Efe C; Taşçılar K; Gerussi A; Bolis F; Lammert C; Ebik B; Stättermayer AF; Cengiz M; Gökçe DT; Cristoferi L; Peralta M; Massoumi H; Montes P; Cerda E; Rigamonti C; Yapalı S; Adali G; Çalışkan AR; Balaban Y; Eren F; Eşkazan T; Barutçu S; Lytvyak E; Zazueta GM; Kayhan MA; Heurgue-Berlot A; De Martin E; Yavuz A; Bıyık M; Narro GC; Duman S; Hernandez N; Gatselis NK; Aguirre J; Idilman R; Silva M; Mendizabal M; Atay K; Güzelbulut F; Dhanasekaran R; Montano-Loza AJ; Dalekos GN; Ridruejo E; Invernizzi P; Wahlin S
    J Autoimmun; 2022 Oct; 132():102906. PubMed ID: 36088883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy.
    Paggi R; Barbiero A; Manciulli T; Miftode A; Tilli M; Lagi F; Mencarini J; Borchi B; Pozzi M; Bartalesi F; Spinicci M; Martini L; Coppola A; Nozzoli C; Peris A; Bonizzoli M; Pieralli F; Bartoloni A; Zammarchi L
    Intern Emerg Med; 2023 Apr; 18(3):821-830. PubMed ID: 36853393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2.
    Grima AA; Murison KR; Simmons AE; Tuite AR; Fisman DN
    Clin Infect Dis; 2023 Feb; 76(3):e409-e415. PubMed ID: 35616115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.
    Mirouse A; Friol A; Moreau AS; Jung B; Jullien E; Bureau C; Djibré M; de Prost N; Zafrani L; Argaud L; Reuter D; Calvet L; de Montmollin E; Benghanem S; Pichereau C; Pham T; Cacoub P; Biard L; Saadoun D
    Sci Rep; 2023 Feb; 13(1):1902. PubMed ID: 36732353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
    Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
    Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.